The potential therapeutic benefits of ibogaine justify its severe cardiac risks

From the articleElite CEOs pay $20K to endure a psychedelic 'hell ride' that rewires the human brainAlso in US advances first government-funded trials of psychedelic drug ibogaine | Reuters, FDA Seeks Public Input to Support Ibogaine Research